Development of a Multiplexed qPCR Kit for the Detection of Bloodstream Infection
Journal of Clinical Laboratory Analysis · 2025
DOI: 10.1002/jcla.70037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2025. Verfasst von Kai Niu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center for Basic and Translational Research, the 2nd Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: Bacteremia, Multiplex Polymerase Chain Reaction, Real-Time Polymerase Chain Reaction, Sepsis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ningbo Science and Technology Innovation 2025 Major Special Project.
Abstract (Originalsprache)
Background
Bloodstream infection (BSI) is associated with high morbidity and mortality worldwide. Currently, BSI diagnosis relies on a time‐consuming blood culture method, which usually takes 2 or more days to identify the causative pathogens. Cell‐free DNA (cfDNA) refers to those small nucleic acid fragments residing in plasma and other body fluids, which have been used to detect cancer, organ transplantation injury, and pathogenic infections. A new multiplexed fluorescent quantitative PCR kit aiming at plasma microbial cfDNA was developed in this study. The kit contains multiple panels, and each panel covers multiple pathogens, including E. coli , K. pneumoniae , A. baumannii , H. influenzae , P. aeruginosa , E. faecalis , E. faecium , S. aureus , and S. epidermidis .
Methods
PCR primers and probes were designed based on effective bacterial sequence segments, which were obtained from the analysis of next‐generation sequencing results of plasma samples of patients with bloodstream infections. Bioinformatics analyses and experimental evidence were used to test the conservativeness and specificity of the primers and probes. The lower detection limit of the kit was determined under optimal reaction conditions. Clinical samples were used to test the accuracy of the kit's detection.
Results
The lower detection limit of the kit has reached ≤ 12 copies per reaction. Clinical samples testing results showed a 90.48% consistency between the kit and blood culture.
Conclusion
The kit provides a rapid, accurate, and reliable method for diagnosing bloodstream infections. This can quickly provide an etiological basis for clinical diagnosis and further treatment, potentially improving patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Basic and Translational Research, the 2nd Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
- Ningbo Health Gene Technologies co., ltd., Ningbo, China.
- The Clinical Laboratory Department of the Affiliated People's Hospital of Ningbo University, Ningbo, China.
ORCID-Profile: Dijun Zhang, Jiang Cao
Förderung
- Ningbo Science and Technology Innovation 2025 Major Special Project
Zitieren
APA
Niu, K., Wang, Y., Pang, Z., Niu, M., Sun, Z., Luo, J., Xia, C., Qian, Y., Xu, Z., Luo, Y., Wu, Y., Zhang, D., & Cao, J. (2025). Development of a Multiplexed qPCR Kit for the Detection of Bloodstream Infection. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.70037
Vancouver
Niu K, Wang Y, Pang Z, Niu M, Sun Z, Luo J, et al. Development of a Multiplexed qPCR Kit for the Detection of Bloodstream Infection. Journal of Clinical Laboratory Analysis. 2025. doi:10.1002/jcla.70037
BibTeX
@article{Niu2025,
author = {Niu, Kai and Wang, Yiping and Pang, Zhiyu and Niu, Miaomiao and Sun, Zhitong and Luo, Jennie and Xia, Chaoqun and Qian, Yanqiao and Xu, Zhi and Luo, Yong and Wu, Yong and Zhang, Dijun and Cao, Jiang},
title = {Development of a Multiplexed qPCR Kit for the Detection of Bloodstream Infection},
journal = {Journal of Clinical Laboratory Analysis},
year = {2025},
doi = {10.1002/jcla.70037}
}
EUVIMED